As applications of generative AI (GenAI), and AI in general, extend to every industry, the dialogue surrounding its responsible integration remains front and centre.
Sanofi has deepened an existing collaboration with artificial intelligence specialist Aqemia in the latest among a flurry of collaborations between pharma companies and ge
AstraZeneca has agreed a deal worth up to $247 million with US generative artificial intelligence (GenAI) company Absci that will focus on the discovery of a new antibody-
Dutch-Swiss start-up Cradle has raised €22 million ($24 million) in first-round financing to develop its generative artificial intelligence (GenAI) and synthetic biology p
In another example of the pharma industry embracing generative artificial intelligence (GenAI), Boehringer Ingelheim will use technology developed by IBM to rev up antibod
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
